V

Vial

94 employees

Vial is a CRO delivering faster and more efficient trials for sponsors through its end-to-end technology platform

Basic info

Industry

research services
biotechnology research

Sectors

Biotechnology
Contract Research Organization
Gastroenterology CRO
Neurology CRO
Dermatology Research
Neurology Research
Clinical Trials
Gastroenterology Research
Technology Platform
Dermatology Clinical Trials
Health Care
Ophthalmology Research
Cardiology CRO
Oncology CRO
Oncology Research
Ophthalmology CRO
Medical
Dermatology CRO
Cardiology Research

Date founded

2020

Funding rounds raised

Total raised

$67M

from 4 investors over 4 rounds

V

Vial raised $67M on November 30, 2022

Investors: General Catalyst

V

Vial raised $34M on November 30, 2022

Investors: General Catalyst and Buckley Ventures

V

Vial raised undisclosed on April 15, 2021

Investors: Buckley Ventures

FAQ